escitalopram + oxytocin

Escitalopram + oxytocin is a combination therapy involving the selective serotonin reuptake inhibitor (SSRI) escitalopram and the neuropeptide hormone oxytocin. Escitalopram acts by selectively inhibiting the serotonin transporter, increasing synaptic serotonin levels, and is primarily used for major depressive disorder and anxiety disorders. Oxytocin, administered intranasally in this context, is a peptide hormone involved in social bonding and stress modulation; it has been investigated as an adjunct to antidepressants for its potential anxiolytic and antidepressant effects. This combination has been studied in treatment-resistant depression, where adjunctive intranasal oxytocin with escitalopram showed significant reduction in depressive symptoms over four weeks[3][5][6]. The mechanism of action involves both serotonergic modulation (escitalopram) and possible enhancement of social cognition or stress response regulation (oxytocin).